78415-72-2
Chemical Structure
Milrinone
Synonym(s): Win 47203
- CAS No.: 78415-72-2
- Formula:C12H9N3O
- Molecular Weight:211.22
IUPAC Name: 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile
InChIKey: PZRHRDRVRGEVNW-UHFFFAOYSA-N
SMILES: CC(N1)=C(C2=CC=NC=C2)C=C(C#N)C1=O
Biological Activity: Milrinone (Win 47203) is a selective PDE3 inhibitor with positive inotropic and vasodilatory effects. Milrinone inhibits cAMP hydrolysis and increases intracellular cAMP and PKA signaling. Milrinone reduces NF-κB, TLR4/MyD88, and NLRP3 inflammasome signaling and pro-inflammatory cytokine production, and has antioxidant and anti-apoptotic effects. Milrinone can be used in research on ischemia/reperfusion injury, sepsis, noise-induced hearing loss, acute lung injury, and Alzheimer's disease[1][2][3][4][5][6][7][8][9].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Milrinone | 99.86% | Milrinone (Win 47203) is a selective PDE3 inhibitor with positive inotropic and vasodilatory effects. Milrinone inhibits cAMP hydrolysis and increases intracellular cAMP and PKA signaling. Milrinone reduces NF-κB, TLR4/MyD88, and NLRP3 inflammasome signaling and pro-inflammatory cytokine production, and has antioxidant and anti-apoptotic effects. Milrinone can be used in research on ischemia/reperfusion injury, sepsis, noise-induced hearing loss, acute lung injury, and Alzheimer's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Milrinone (Standard) | ≥98% | Milrinone (Standard) (Win 47203 (Standard)) is the analytical standard of Milrinone (HY-14252). This product is intended for research and analytical applications. Milrinone (Win 47203) is a selective PDE3 inhibitor with positive inotropic and vasodilatory effects. Milrinone inhibits cAMP hydrolysis and increases intracellular cAMP and PKA signaling. Milrinone reduces NF-κB, TLR4/MyD88, and NLRP3 inflammasome signaling and pro-inflammatory cytokine production, and has antioxidant and anti-apoptotic effects. Milrinone can be used in research on ischemia/reperfusion injury, sepsis, noise-induced hearing loss, acute lung injury, and Alzheimer's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Milrinone solution | Milrinone solution (Win 47203 solution) is a selective PDE3 inhibitor with positive inotropic and vasodilatory effects. Milrinone solution inhibits cAMP hydrolysis and increases intracellular cAMP and PKA signaling. Milrinone solution reduces NF-κB, TLR4/MyD88, and NLRP3 inflammasome signaling and pro-inflammatory cytokine production, and has antioxidant and anti-apoptotic effects. Milrinone solution can be used in research on ischemia/reperfusion injury, sepsis, noise-induced hearing loss, acute lung injury, and Alzheimer's disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Milrinone-d3 | Milrinone-d3 is the deuterated-labeled Milrinone (HY-14252). Milrinone (Win 47203) is a selective PDE3 inhibitor with positive inotropic and vasodilatory effects. Milrinone inhibits cAMP hydrolysis and increases intracellular cAMP and PKA signaling. Milrinone reduces NF-κB, TLR4/MyD88, and NLRP3 inflammasome signaling and pro-inflammatory cytokine production, and has antioxidant and anti-apoptotic effects. Milrinone can be used in research on ischemia/reperfusion injury, sepsis, noise-induced hearing loss, acute lung injury, and Alzheimer's disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.81
HY-19089DPN-205-734 -
Similarity Score 0.81
HY-108975OK-1035 -
Similarity Score 0.77
HY-W100186Win 47338 -
Similarity Score 0.74
HY-105418WIN-63291 -
Similarity Score 0.74
HY-14254AOlprinone -
Similarity Score 0.73
HY-14254Olprinone Hydrochloride -
Similarity Score 0.64
HY-U00136Win-62005 -
Similarity Score 0.61
HY-W667926[4,4'-Bipyridine]-2,2'-dicarbonitrile -
Similarity Score 0.60
HY-W855988[4,2':5',4''-Terpyridine]-4'-carbonitrile -
Explore the MedChemAI to find more analogs
References
- [1]. Hentschel T, et al. Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiology. 2007 Jan;106(1):124-31. [Content Brief]
- [2]. Raupach A, et al. Milrinone-Induced Pharmacological Preconditioning in Cardioprotection: Hints for a Role of Mitochondrial Mechanisms. Journal of clinical medicine. 2019 Apr 12;8(4):507.
- [3]. Kölükçü E, et al. Milrinone ameliorates ischaemia-reperfusion injury in experimental testicular torsion/detorsion rat model. Andrologia. 2021 Sep;53(8):e14128.
- [4]. Keskin H, et al. Early administration of milrinone ameliorates lung and kidney injury during sepsis in juvenile rats. Pediatrics international : official journal of the Japan Pediatric Society. 2022 Jan;64(1):e14917.
- [5]. Ceylan SM, et al. Protective and therapeutic effects of milrinone on acoustic trauma in rat cochlea. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2019 Jul;276(7):1921-1931.
- [6]. Jung HS, et al. Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice. Korean journal of anesthesiology. 2014 Feb;66(2):136-42.
- [7]. Bueltmann M, et al. Inhaled milrinone attenuates experimental acute lung injury. Intensive care medicine. 2009 Jan;35(1):171-8.
- [8]. Chen Q, et al. Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer's Disease in an APP/PS1 Mouse Model. Neuropsychiatr Dis Treat. 2021 Jun 30;17:2129-2139.
- [9]. Chanani NK, et al. Differential effects of amrinone and milrinone upon myocardial inflammatory signaling. Circulation. 2002 Sep 24;106(12 Suppl 1):I284-9.